Publish in this journal
Journal Information
Vol. 68. Issue 10.
Pages 885-891 (October 2015)
Download PDF
More article options
Not available
Vol. 68. Issue 10.
Pages 885-891 (October 2015)
Update: Acute Heart Failure (VIII)
DOI: 10.1016/j.rec.2015.05.008
Full text access
Multidisciplinary Approach for Patients Hospitalized With Heart Failure
Abordaje multidisciplinario en pacientes hospitalizados por insuficiencia cardiaca
Lutz Frankensteina,
Corresponding author

Corresponding author: Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany.
, Hanna Fröhlicha, John G.F. Clelandb
a Department of Cardiology, Angiology and Pulmology, University Hospital Heidelberg, Heidelberg, Germany
b National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, United Kingdom
This item has received
(Daily data update)
Article information
Full Text
Download PDF
Figures (1)
Tables (1)
Table. In-hospital Specialists Involved in the Diagnosis and Treatment of Acute Heart Failure

Acute heart failure describes the rapid deterioration, over minutes, days or hours, of symptoms and signs of heart failure. Its management is an interdisciplinary challenge that requires the cooperation of various specialists. While emergency providers, (interventional) cardiologists, heart surgeons, and intensive care specialists collaborate in the initial stabilization of acute heart failure patients, the involvement of nurses, discharge managers, and general practitioners in the heart failure team may facilitate the transition from inpatient care to the outpatient setting and improve acute heart failure readmission rates. This review highlights the importance of a multidisciplinary approach to acute heart failure with particular focus on the chain-of-care delivered by the various services within the healthcare system.

Acute heart failure
Multidisciplinary management

La insuficiencia cardiaca aguda describe el deterioro rápido, en un plazo de minutos, días u horas, de los signos y síntomas de la insuficiencia cardiaca. Su tratamiento constituye un verdadero reto interdisciplinario que requiere la colaboración de diversos especialistas. Aunque los servicios de urgencias, los cardiólogos (intervencionistas), los cirujanos cardiacos y los especialistas en cuidados intensivos colaboran en la estabilización inicial de los pacientes con insuficiencia cardiaca aguda, la participación en el equipo de asistencia de enfermeras, encargados del alta y médicos generales puede facilitar la transición de la asistencia hospitalaria al contexto ambulatorio, y reducir las tasas de reingreso por insuficiencia cardiaca aguda. En esta revisión se señala la importancia de un abordaje multidisciplinario de la insuficiencia cardiaca aguda, con especial énfasis en la cadena de asistencia prestada por los diversos servicios dentro del contexto del sistema de asistencia sanitaria.

Palabras clave:
Insuficiencia cardiaca aguda
Tratamiento multidisciplinario
Full Text

Acute heart failure (AHF) describes the rapid onset or worsening of symptoms and signs of heart failure (HF),1 usually leading to hospitalization. It is a life-threatening condition and the most common diagnosis among patients suffering from acute respiratory distress.2,3 The term AHF is also often extended to patients with more gradual deterioration, with increasing exertional dyspnea and worsening peripheral edema and for this reason some people have coined the term “hospitalized HF” as a more accurate reflection of the clinical problem.4 Although worsening peripheral edema may appear less alarming than pulmonary edema, it may carry a worse prognosis, perhaps because it reflects biventricular rather than only left ventricular failure.5

Heart failure is common6 and there has been a steady rise in AHF admissions over the last decade.7–9 An aging population and improved survival after the onset of cardiovascular disease is expected to further increase HF incidence and prevalence.10 Most people who die of cardiovascular diseases will first develop HF.11 The management of HF is an interdisciplinary challenge that requires the cooperation of various specialists (Figure).


Multidisciplinary approach to heart failure. HF, heart failure; ICU, intensive care unit.


Patients suffering from AHF may contact emergency medical services (EMS) because of acute symptoms such as dyspnoea, syncope, palpitations, or thoracic pain. An analysis of 4083 consecutive EMS contacts in Denmark found HF to be the primary discharge diagnosis in 3.1% of these patients.12 However, AHF may also be present in patients with other primary diagnoses such as acute coronary syndrome, arrhythmia, or valvular disease. Based on physical signs and symptoms alone, the prehospital diagnosis of AHF can be challenging.13–15 Studies on the accuracy of EMS diagnosis and treatment of AHF found rates of error ranging from 9%14 to 23%.15 While EMS treatment overall seems to improve the survival of AHF patients,13,16 erroneous diagnosis and treatment may on the other hand result in increased mortality rates.16 The organization and structure of EMS vary amongst geographical regions and may include paramedics, technicians, nurses, and physicians. Therefore, studies on the performance of EMS treatment in AHF are difficult to compare. However, the interdisciplinary cooperation of EMS teams as well as a structured handover to the hospital physician is likely to be important in the emergency care of AHF. Further research is warranted to improve the prehospital management of AHF patients.


Emergency providers play an important role in the management of patients with AHF, as patients commonly present to the emergency departments of local hospitals (either self-directed or via EMS). Indeed, most cases of HF are first diagnosed in hospital rather than in primary care.17 More than 80% of emergency department patients with AHF are admitted to hospital, a proportion that has remained largely unchanged over the past 5 years.8 It is crucial that emergency providers recognize the clinical presentation of AHF, as correct diagnosis is a prerequisite for successful treatment.1 Studies show that therapeutic and management decisions made by emergency providers have a direct impact on morbidity, mortality, and hospital length of stay, all of which affect health care costs.18–20 The accuracy of the diagnosis of AHF in emergency departments is reported to vary between 71%21 and 95%.22 Patients with AHF seen in high-volume emergency departments seem to have better outcomes than patients who present to low-volume emergency departments.18 On the other hand, patients with AHF may also present after admission to any hospital ward, either as a consequence of another cardiovascular problem (eg, acute coronary syndrome/arrhythmia) or because they have cardiac disease complicating a noncardiac problem (eg, patients with hip fractures are often elderly and have hypertension and/or coronary disease) or as an iatrogenic complication (eg, excessive fluid replacement on surgical wards).


Heart failure outcomes are better for patients when they are admitted under specialist cardiology medical staff or have specialist HF input into their care.23–26 The first days following hospital admission are a high-risk period for the patient, when the diagnosis must be clarified or revisited, reversible factors addressed, evidence-based therapies started, comorbidities treated, and the post-discharge management planned. The European Society of Cardiology Heart Failure Association Standards for delivering HF care guideline therefore advises that all tertiary/teaching/university hospital referral centers should have an individual with a specific interest and expertise in HF among their cardiology staff/faculty. Ideally, 25% of the cardiology staff in tertiary/teaching/university hospital referral centers should have a HF remit.27


Depending on the clinical presentation of the patient and the cause for AHF, a variety of in-hospital specialists may be involved in the comprehensive care of the patient (Table).


In-hospital Specialists Involved in the Diagnosis and Treatment of Acute Heart Failure

Clinical finding  Expertise  Care 
Hypotension/cardiogenic shock  Intensive medical careCatecholamines, volume management, CPR 
Respiratory insufficiency/gross peripheral edema (anasarca)  Forced diuresis, tap pleural effusion, (non)-invasive ventilation, hemo-/ultra-filtration, stop NSAID 
Hemodynamic instability  Invasive monitoring 
ArrhythmiaCardioversion, pacing 
(Interventional) cardiologyPacemaker/ICD 
Acute myocardial infarction  Coronary reperfusion 
Hypotension/cardiogenic shock  Mechanical circulatory support (IABP, Impella, ECMO, etc.) 
Cardiac tamponade  Tap 
Acute valvular diseaseValve replacement/repair
Heart surgery
Acute myocardial infarction  Coronary bypass 
Acute ischemic ventricular rupture  Repair 
Refractory heart failureHigh urgent heart transplantation 
Assist device implantation (IABP, LVAD, BIVAD, etc.) 
Acute renal failure (CRS type 1)  NephrologyPharmacotherapy, renal replacement therapy
Chronic kidney disease 
Severe hyper-/hypothyroidism  Endocrinology  Identification and treatment 
Cachexia  Appropriate nutrition  Appropriate alimentation 
Polypharmacy  Pharmacy  Medication reconciliation 
Depression  Psychotherapy  Psychotherapy, medication 
Weakness, immobilization, fatigueNursery, physiotherapy  Mobilization, physiotherapy, education 
Discharge management  Procurement of rehabilitation/home care/hospice care 

BIVAD, biventricular assist device; CPR, cardiopulmonary resuscitation; CRS, cardiorenal syndrome; ECMO, extracorporal membrane oxygenation; IABP, intra-aortal balloon pump; ICD, implantable cardioverter defibrillator; LVAD, left ventricular assist device; NSAID, nonsteroidal anti-inflammatory drugs.


Several transitions of care, such as emergency department to intensive care unit, intensive care unit to ward, and ward to home, often occur subsequent to discharge. These transitions are often associated with changes in the patient's medication: guideline-mandated treatments may be stopped or initiated and/or their doses or their mode of administration may be changed.28 Any breakdown in communication during these in-hospital transitions commonly reflects on medication regimens and may adversely impact patient care.29,30 Cessation or dose-reduction of guideline-indicated treatments is often intended only as a temporary measure but poor organization of care may fail to reinstate life-saving therapies after the acute problem has been solved. Transitioning between intravenous and oral diuretics also requires considerable experience. Prospective studies found that more than 50% of patients admitted to hospital had at least 1 unintended discrepancy between their chronic outpatient medication and their admission regimen.29,31 Then again, medication reconciliation performed by clinical pharmacists may improve medication adherence.32 In-hospital transitions contribute to longer lengths of stay and miscommunication. Care pathways should try to minimize the need for them. When in-hospital transitions occur, all staff involved need to communicate professionally to avoid unintentional erroneous treatment.


Once hospitalized for HF, the 30-day readmission rate approaches 25% to 50%.33 Studies investigating the determinants of HF rehospitalizations have identified comorbidities and markers of HF severity as risk factors for HF readmissions.34–36 In addition, patients with limited education and those with a foreign mother language are more likely to have poorer understanding of their condition and higher rates of 30-day readmissions.37 Hospital-based disease management programs as well as nurse-led discharge planning reduce rehospitalization rates in HF patients. Unfortunately, interventions based primarily on patient education have been shown not to reduce readmission or mortality rates.33,38–41 The National Heart Failure Audit for England and Wales enrolled more than 75 000 patients with a primary discharge diagnosis of HF. About half of patients were followed-up by a HF specialist team, which was associated with a substantially better outcome; 3-year mortality was 70% in those who did not receive specialist follow-up but only 50% in those who did.42 An analysis of the Get With The Guidelines® program including 57 969 patients hospitalized with HF between 2005 and 2010 found that referral to a HF disease management program occurred in less than one-fifth of hospitalized HF patients. Paradoxically, patients with a worse prognosis were less likely to be referred.43

Thus, increasing the availability of HF disease management programs and optimizing selection for these programs might improve the quality and effectiveness of care. A well-orchestrated team of cardiologists, general practitioners, nurses, and ancillary support staff seems important for an integrated and seamless transition from inpatient care to the outpatient setting.44


The role of the HF specialist nurse varies depending on the regional organization of medical care. It may involve home visits, telephone contact, facilitating telemonitoring, running nurse-led clinics, participating in cardiologist-led clinics, or a combination of these, as well as providing education for health professionals involved in the management of the patient.45 The HF nursing service should function as a key link between secondary and primary care. Although the COACH study46—one of the largest randomized trials that compared disease management by a specialized HF nurse with standard follow-up by a cardiologist—did not show a reduction in the combined endpoints of death and HF hospitalization, other studies suggest that a HF nursing service may reduce morbidity and mortality.47 In 2012, a systematic review performed by the Cochrane Collaboration concluded that there is good evidence that case management-type interventions led by a HF specialist nurse reduce HF-related 12-months readmissions, all-cause readmissions, and all-cause mortality in patients recently discharged after a hospital admission for HF.47

Geographical considerations and/or the needs of the patient population being cared for may make telephone-assisted management or telemonitoring a useful method to improve the efficiency and effectiveness of the nursing team.27 Although outcome data for remote monitoring are conflicting, the bulk of evidence points toward a benefit of home telemonitoring on mortality and a modest effect on hospitalization in patients with a recent HF hospitalization.48,49 In contrast, well managed, stable chronic HF patients may not benefit from telemonitoring.50–52 Another large randomized trial, the BEAT-HF study,53 is ongoing. Its results may help to clarify the role of home telemonitoring in HF patients.


Bed-rest is appropriate for the patient with pulmonary or severe peripheral edema as it conserves blood flow to essential organs, reduces cardiac work, and improves diuresis. Once the patient has been stabilized, European guidelines advise early mobilization through an individualized exercise program after hospitalization for an exacerbation of HF to prevent further disability and lay good foundations for the formal exercise training plan.54,55 In this early phase after decompensation, cardiac rehabilitation may include respiratory training, small muscle strength exercise, or simply increasing activities of daily living such as walking.54,55 Cardiac rehabilitation may also include self-care counselling that targets improved education and skill development (eg, medication compliance, monitoring/management of body weight). When clinical stabilization is achieved, exercise-based rehabilitation reduces the risk of hospital admissions and confers important improvements in health-related quality of life.56,57 As a universal agreement on exercise prescription in HF does not exist, an individualized approach is recommended, with careful clinical evaluation, including behavioral characteristics, personal goals, and preferences.54


A robust HF management program must include the primary care physician as an important member of the multiprofessional team. Primary care physicians are often the first port of call for patients who have new or worsening symptoms/signs potentially due to HF. They play an essential role in titrating and monitoring guideline-indicated therapy and a key role in terminal care at home.27 In some countries, office-based cardiologists may also be involved in the HF team. The comanagement of HF patients by a primary care physician and a cardiologist has been shown to reduce both all-cause mortality and hospitalizations for AHF when compared with HF patients managed solely by primary care physicians.58,59 This may be explained by more effective implementation of target doses of medication and timely device implantation.60,61 Patients cared for by physicians that see only a few patients with HF may have worse outcomes,62 although this might be partly explained by differences in the sorts of patients managed by general physicians rather than cardiologists.63


Heart failure guidelines indicate that palliative care should be integrated into the overall provision of care for patients with HF.1 The American Center to Advance Palliative Care defines subspecialty palliative care as follows64: “Specialized medical care for people with serious illnesses. This type of care is focused on providing patients with relief from the symptoms, pain, and stress of a serious illness–whatever the diagnosis or prognosis. The goal is to improve quality of life for both the patient and the family. Palliative care is delivered by a team of doctors, nurses, and other specialists who work with the patient's doctors to provide an extra layer of support”. Thus, palliative care is appropriate at any stage in a serious illness and can be provided together with curative treatment.65 Although studies show that palliative care improves quality of life and morbidity of HF patients,66–68 few patients with HF receive care from palliative care specialists.69–71 A recently published study explored barriers to palliative care referrals in HF from cardiology and primary care providers.72 Identified barriers included lack of knowledge about the field of palliative care, lack of appropriate triggers for referral, and discomfort with the term palliative care. Future work should seek to develop provider–and patient–centred interventions to reduce actionable barriers to palliative care uptake in HF.


A hospice uses an interdisciplinary approach to deliver medical, social, physical, emotional, and spiritual services through the use of a broad spectrum of caregivers within a defined time frame at the end of life.73 The Centers for Medicare and Medicaid Services definition of hospice is: “Care that allows the terminally ill patient to remain at home as long as possible by providing support to the patient and family and keeping the patient as comfortable as possible while maintaining his or her dignity and quality of life”.73 While hospice care was initially geared only towards the care of patients with cancer, any terminal illness with less than 6-month predicted survival currently qualifies for its institution.

Although heart disease is the leading cause of death in Western countries, there is a lingering disparity between the use of hospice and palliative services in patients with advanced HF compared with cancer. Of 58330 patients aged ≥ 65 years participating in the Get With The Guidelines® HF program, only 2.5% were discharged to a hospice.74 In 2012, only 11.4% of United States hospice patients had a primary diagnosis of heart disease.75 In addition, it was estimated that only between 11% and 39% of patients who died of advanced HF were enrolled in hospice programs.76–78 Heart failure patients entering hospice care have multiple symptoms requiring management, many of which cause considerable distress.79 Noteworthy is the finding that symptoms with the greatest reported severity were not necessarily those causing the greatest distress, as well as the relationship between symptom distress and depressive symptoms.79 Clinicians in hospices may consider specifically focusing part of their assessment and management by first addressing symptom severity and distress.


Treatment of HF is complex, requiring attention to diet, lifestyle, complex therapeutic regimens, and device therapy. In daily clinical life, many patients have difficulties adopting complex care regimens and adherence to evidence-based regimens remains low. Therefore, facilitating a more active role for patients in self-management of long-term medical conditions is an essential component of good clinical care. Patients may be considered the largest health care workforce available.80 There is, however, conflicting evidence as to the potential benefits of patient education and self-management on hospitalization rates and mortality.80–83 In the HART study,82 self-management counselling plus HF education did not reduce the primary endpoint of death or HF hospitalization compared with HF education alone in 902 patients with mild to moderate HF. In contrast, formal education and support intervention was shown by others81,83 to reduce adverse clinical outcomes and costs for patients with HF, while it had positive effects on quality of life, exercise capacity, and plasma concentrations of cardiac peptides.


Current HF guidelines recommend that HF patients are enrolled in a multidisciplinary-care management program to reduce the risk of HF hospitalization.1 A multidisciplinary approach to HF may reduce costs,84 decrease length of stay,85–88 curtail readmissions,86–95 improve compliance,90,96,97 and reduce mortality.91,92,94,96,98 An important limitation, however, is the substantial heterogeneity in both the terms of the models of care and the interventions offered, including: clinic or community-based systems of care, remote management, and enhanced patient self-care.27

A meta-analysis of 30 trials (7532 patients) on multidisciplinary interventions in HF found that all-cause hospital admission rates, HF admission rates and all-cause mortality were reduced by 14%, 30%, and 20%, respectively.92 The positive effects, however, varied with respect to the intervention applied: provision of home visits reduced all-cause admissions but not all-cause mortality, whereas telephone follow-up did not influence hospital admissions but reduced all-cause mortality. Hospital/clinic interventions, in contrast, had no impact on either all-cause hospitalization or all-cause mortality. Another review of 29 randomized trials (5039 patients) on multiprofessional strategies for the management of HF patients reported that follow-up by a specialized multidisciplinary team (either in a clinic or a nonclinic setting) reduced mortality, HF hospitalizations, and all-cause hospitalizations, while programs that focused on enhancing patient self-care activities reduced HF hospitalizations and all-cause hospitalizations but had no effect on mortality.94 Strategies that employed telephone contact and advised patients to attend their primary care physician in the event of deterioration reduced HF hospitalizations but not mortality or all-cause hospitalizations.

Thus, there remains considerable uncertainty about which components of multidisciplinary HF care are most important. For example, are beneficial effects mediated through more aggressive medication titration (as proposed by Mao et al91), or through enhanced surveillance? Conventional trials that randomize individual patients may not be the best way to test the effect of a service; novel approaches, such as the cluster randomized controlled trial, may be superior.49

It is unlikely that any one approach is optimal. The best form of care might seek to compensate for the weaknesses of each approach by exploiting their strengths. A strong HF cardiology lead, supported by primary care physicians, nurse specialists, and pharmacists in the hospital and community with the ability to offer patients remote support might offer the best service.

Key to the success of multidisciplinary HF programs may be the coordination of care along the spectrum of severity of HF and throughout the chain-of-care delivered by the various services within the healthcare system.1 Further research is warranted to identify the most efficacious multidisciplinary approaches to AHF.


J.G.F. Cleland reports research support from Amgen, Novartis, and Servier. L. Frankenstein reports research support from Roche, Novartis, and Servier.

J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Bohm, K. Dickstein, et al.
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.
Eur J Heart Fail., 14 (2012), pp. 803-869
M.E. Prekker, L.C. Feemster, C.L. Hough, D. Carlbom, K. Crothers, D.H. Au, et al.
The epidemiology and outcome of prehospital respiratory distress.
Acad Emerg Med., 21 (2014), pp. 543-550
E. Burri, K. Hochholzer, N. Arenja, H. Martin-Braschler, L. Kaestner, H. Gekeler, et al.
B-type natriuretic peptide in the evaluation and management of dyspnoea in primary care.
J Intern Med., 272 (2012), pp. 504-513
M. Gheorghiade, A. Shah, M. Vaduganathan, J. Butler, R.O. Bonow, S. Taylor, et al.
Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics’, clinicians’, industry's, regulators’, and payers’ perspectives.
Heart Fail Clin., 9 (2013), pp. 285-290
A. Shoaib, M. Waleed, S. Khan, A. Raza, M. Zuhair, X. Kassianides, et al.
Breathlessness at rest is not the dominant presentation of patients admitted with heart failure.
Eur J Heart Fail., 16 (2014), pp. 1283-1291
F. De Giuli, K.T. Khaw, M.R. Cowie, G.C. Sutton, R. Ferrari, P.A. Poole-Wilson.
Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom.
Eur J Heart Fail., 7 (2005), pp. 295-302
M.J. Hall, C.J. DeFrances, S.N. Williams, A. Golosinskiy, A. Schwartzman.
National Hospital Discharge Survey: 2007 summary.
Natl Health Stat Report., (2010), pp. 1-20
A.B. Storrow, C.A. Jenkins, W.H. Self, P.T. Alexander, T.W. Barrett, J.H. Han, et al.
The burden of acute heart failure on U.S. emergency departments.
JACC Heart Fail., 2 (2014), pp. 269-277
S.P. Collins, A.B. Storrow, P.D. Levy, N. Albert, J. Butler, J.A. Ezekowitz, et al.
Early management of patients with acute heart failure: state of the art and future directions-a consensus document from the SAEM/HFSA Acute Heart Failure Working Group.
Acad Emerg Med., 22 (2015), pp. 94-112
A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, et al.
Heart disease and stroke statistics - 2014 update: a report from the American Heart Association.
Circulation., 129 (2014), pp. e28-e292
A. Torabi, J.G. Cleland, N.K. Khan, P.H. Loh, A.L. Clark, F. Alamgir, et al.
The timing of development and subsequent clinical course of heart failure after a myocardial infarction.
Eur Heart J., 29 (2008), pp. 859-870
M.M. Schoos, M. Sejersten, U. Baber, P.M. Treschow, M. Madsen, A. Hvelplund, et al.
Outcomes of patients calling emergency medical services for suspected acute cardiovascular disease.
Am J Cardiol., 115 (2015), pp. 13-20
S.E. Shapiro.
Evidence review: emergency medical services treatment of patients with congestive heart failure/acute pulmonary edema: do risks outweigh benefits?.
J Emerg Nurs., 31 (2005), pp. 51-57
quiz 118-9.
S.J. Rottman, D.L. Schriger, G. Charlop, J.H. Salas, S. Lee.
On-line medical control versus protocol-based prehospital care.
Ann Emerg Med., 30 (1997), pp. 62-68
J.R. Hoffman, S. Reynolds.
Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema.
Chest., 92 (1987), pp. 586-593
R.C. Wuerz, S.A. Meador.
Effects of prehospital medications on mortality and length of stay in congestive heart failure.
Ann Emerg Med., 21 (1992), pp. 669-674
M.R. Cowie, D.A. Wood, A.J. Coats, S.G. Thompson, P.A. Poole-Wilson, V. Suresh, et al.
Incidence and aetiology of heart failure: a population based study.
Eur Heart J., 20 (1999), pp. 421-428
S. Brar, F.A. McAlister, E. Youngson, B.H. Rowe.
Do outcomes for patients with heart failure vary by emergency department volume?.
Circ Heart Fail., 6 (2013), pp. 1147-1154
J.E. Rame, M.A. Sheffield, D.L. Dries, E.B. Gardner, K.H. Toto, C.W. Yancy, et al.
Outcomes after emergency department discharge with a primary diagnosis of heart failure.
Am Heart J., 142 (2001), pp. 714-719
A.J. Singer, R.H. Birkhahn, D. Guss, A. Chandra, C.D. Miller, B. Tiffany, et al.
Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): a randomized controlled trial of the effect of serial B-type natriuretic peptide testing on patient management.
Circ Heart Fail., 2 (2009), pp. 287-293
S.P. Collins, C.J. Lindsell, D.M. Yealy, D.J. Maron, A.J. Naftilan, J.A. McPherson, et al.
A comparison of criterion standard methods to diagnose acute heart failure.
Congest Heart Fail., 18 (2012), pp. 262-271
M.F. Seronde, S. Laribi, S.P. Collins, N. Deye, D. Logeart, P. Plaisance, et al.
Heart failure diagnosis in acute conditions has high agreement with inpatient diagnosis.
Eur J Emerg Med., (2015),
S.E. Reis, R. Holubkov, D. Edmundowicz, D.M. McNamara, K.A. Zell, K.M. Detre, et al.
Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes.
J Am Coll Cardiol., 30 (1997), pp. 733-738
S. Uthamalingam, J. Kandala, V. Selvaraj, W. Martin, M. Daley, E. Patvardhan, et al.
Outcomes of patients with acute decompensated heart failure managed by cardiologists versus noncardiologists.
Am J Cardiol., 115 (2015), pp. 466-471
J.M. Foody, S.S. Rathore, Y. Wang, J. Herrin, F.A. Masoudi, E.P. Havranek, et al.
Physician specialty and mortality among elderly patients hospitalized with heart failure.
Am J Med., 118 (2005), pp. 1120-1125
P. Jong, Y. Gong, P.P. Liu, P.C. Austin, D.S. Lee, J.V. Tu.
Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists.
Circulation., 108 (2003), pp. 184-191
T.A. McDonagh, L. Blue, A.L. Clark, U. Dahlstrom, I. Ekman, M. Lainscak, et al.
European Society of Cardiology Heart Failure Association Standards for delivering heart failure care.
Eur J Heart Fail., 13 (2011), pp. 235-241
S. Kripalani, A.T. Jackson, J.L. Schnipper, E.A. Coleman.
Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.
J Hosp Med., 2 (2007), pp. 314-323
P.L. Cornish, S.R. Knowles, R. Marchesano, V. Tam, S. Shadowitz, D.N. Juurlink, et al.
Unintended medication discrepancies at the time of hospital admission.
Arch Intern Med., 165 (2005), pp. 424-429
K.M. Gleason, J.M. Groszek, C. Sullivan, D. Rooney, C. Barnard, G.A. Noskin.
Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients.
Am J Health Syst Pharm., 61 (2004), pp. 1689-1695
B.L. Armor, A.J. Wight, S.M. Carter.
Evaluation of adverse drug events and medication discrepancies in transitions of care between hospital discharge and primary care follow-up.
G. Leguelinel-Blache, F. Arnaud, S. Bouvet, F. Dubois, C. Castelli, C. Roux-Marson, et al.
Impact of admission medication reconciliation performed by clinical pharmacists on medication safety.
Eur J Intern Med., 25 (2014), pp. 808-814
M. Adib-Hajbaghery, F. Maghaminejad, A. Abbasi.
The role of continuous care in reducing readmission for patients with heart failure.
J Caring Sci., 2 (2013), pp. 255-267
G. Corrao, A. Ghirardi, B. Ibrahim, L. Merlino, A.P. Maggioni.
Short- and long-term mortality and hospital readmissions among patients with new hospitalization for heart failure: a population-based investigation from Italy.
Int J Cardiol., 181 (2015),
M. Setoguchi, Y. Hashimoto, T. Sasaoka, T. Ashikaga, M. Isobe.
Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.
K.M. Anderson.
Discharge clinical characteristics and 60-day readmission in patients hospitalized with heart failure.
J Cardiovasc Nurs., 29 (2014), pp. 232-241
R. Regalbuto, M.S. Maurer, D. Chapel, J. Mendez, J.A. Shaffer.
Joint Commission requirements for discharge instructions in patients with heart failure: is understanding important for preventing readmissions?.
J Card Fail., 20 (2014), pp. 641-649
R. Berkowitz, L.J. Blank, S.K. Powell.
Strategies to reduce hospitalization in the management of heart failure.
Lippincotts Case Manag., 10 (2005), pp. S1-S15
quiz S16-7
E. Lambrinou, F. Kalogirou, D. Lamnisos, P. Sourtzi.
Effectiveness of heart failure management programmes with nurse-led discharge planning in reducing re-admissions: a systematic review and meta-analysis.
Int J Nurs Stud., 49 (2012), pp. 610-624
S.M. White, A. Hill.
A heart failure initiative to reduce the length of stay and readmission rates.
Prof Case Manag., 19 (2014), pp. 276-284
C. Feltner, C.D. Jones, C.W. Cene, Z.J. Zheng, C.A. Sueta, E.J. Coker-Schwimmer, et al.
Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis.
Ann Intern Med., 160 (2014), pp. 774-784
Cleland J, Dargie H, Hardman S, McDonagh T, Mitchell P. National Heart Failure Audit: April 2012-March 2012. London: National Institute for Cardiovascular Outcomes Research; 2013. Available at:
S.M. Gharacholou, A.S. Hellkamp, A.F. Hernandez, E.D. Peterson, D.L. Bhatt, C.W. Yancy, et al.
Use and predictors of heart failure disease management referral in patients hospitalized with heart failure: insights from the Get With the Guidelines Program.
J Card Fail., 17 (2011), pp. 431-439
A. Amin.
Who is managing acute decompensated heart failure?.The need for a multidisciplinary approach.
J Hosp Med., 3 (2008), pp. S1-S6
K. Rasmusson, M. Flattery, L.S. Baas.
American Association of Heart Failure Nurses position paper on educating patients with heart failure.
Heart Lung., 44 (2015), pp. 173-177
T. Jaarsma, M.H. Van der Wal, I. Lesman-Leegte, M.L. Luttik, J. Hogenhuis, N.J. Veeger, et al.
Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
Arch Intern Med., 168 (2008), pp. 316-324
A. Takeda, S.J. Taylor, R.S. Taylor, F. Khan, H. Krum, M. Underwood.
Clinical service organisation for heart failure.
Cochrane Database Syst Rev., 9 (2012), pp. CD002752
R. Dierckx, P. Pellicori, J.G. Cleland, A.L. Clark.
Telemonitoring in heart failure: Big Brother watching over you.
Heart Fail Rev., 20 (2015), pp. 107-116
A. Steventon, M. Bardsley, J. Billings, J. Dixon, H. Doll, S. Hirani, et al.
Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial.
BMJ., 344 (2012), pp. e3874
A.L. Vuorinen, J. Leppanen, H. Kaijanranta, M. Kulju, T. Helio, M. van Gils, et al.
Use of home telemonitoring to support multidisciplinary care of heart failure patients in Finland: randomized controlled trial.
J Med Internet Res., 16 (2014), pp. e282
F. Koehler, S. Winkler, M. Schieber, U. Sechtem, K. Stangl, M. Bohm, et al.
Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study.
Circulation., 123 (2011), pp. 1873-1880
K. Blum, S.S. Gottlieb.
The effect of a randomized trial of home telemonitoring on medical costs, 30-day readmissions, mortality, and health-related quality of life in a cohort of community-dwelling heart failure patients.
J Card Fail., 20 (2014), pp. 513-521
J.T. Black, P.S. Romano, B. Sadeghi, A.D. Auerbach, T.G. Ganiats, S. Greenfield, et al.
A remote monitoring and telephone nurse coaching intervention to reduce readmissions among patients with heart failure: study protocol for the Better Effectiveness After Transition - Heart Failure (BEAT-HF) randomized controlled trial.
M.F. Piepoli, V. Conraads, U. Corra, K. Dickstein, D.P. Francis, T. Jaarsma, et al.
Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation.
Eur J Heart Fail., 13 (2011), pp. 347-357
R.J. Achttien, J.B. Staal, S. Van der Voort, H.M. Kemps, H. Koers, M.W. Jongert, et al.
Exercise-based cardiac rehabilitation in patients with chronic heart failure: a Dutch practice guideline.
Neth Heart J., 23 (2015), pp. 6-17
R.S. Taylor, V.A. Sagar, E.J. Davies, S. Briscoe, A.J. Coats, H. Dalal, et al.
Exercise-based rehabilitation for heart failure.
Cochrane Database Syst Rev., 4 (2014), pp. CD003331
C. Lewinter, P. Doherty, C.P. Gale, S. Crouch, L. Stirk, R.J. Lewin, et al.
Exercise-based cardiac rehabilitation in patients with heart failure: a meta-analysis of randomised controlled trials between 1999 and.
Eur J Prev Cardiol., (2014),
P.M. Diller, D.R. Smucker, B. David.
Comanagement of patients with congestive heart failure by family physicians and cardiologists: frequency, timing, and patient characteristics.
J Fam Pract., 48 (1999), pp. 188-195
J.A. Ezekowitz, C. Van Walraven, F.A. McAlister, P.W. Armstrong, P. Kaul.
Impact of specialist follow-up in outpatients with congestive heart failure.
CMAJ., 172 (2005), pp. 189-194
C.Y. Chou, T.J. Chen, S.C. Chiang, Y.C. Chen, M.H. Cheng, Y.C. Yang, et al.
Disparity of physician specialties in the management of chronic heart failure: trend analysis in Taiwan, 2000-2010.
Int J Clin Pharmacol Ther., 51 (2013), pp. 678-687
U. Tebbe, C. Tschope, J.H. Wirtz, J. Lokies, E. Turgonyi, P. Bramlage, et al.
Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF.
Clin Res Cardiol., 103 (2014), pp. 665-673
K.E. Joynt, E.J. Orav, A.K. Jha.
Physician volume, specialty, and outcomes of care for patients with heart failure.
Circ Heart Fail., 6 (2013), pp. 890-897
P. Román-Sánchez, P. Conthe, J. García-Alegría, J. Forteza-Rey, M. Montero, C. Montoto.
Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey.
QJM., 98 (2005), pp. 127-138
Center to Advance Palliative Care (CAPC). Available at:
L. Lemond, L.A. Allen.
Palliative care and hospice in advanced heart failure.
Prog Cardiovasc Dis., 54 (2011), pp. 168-178
M. Brannstrom, K. Boman.
Effects of person-centred and integrated chronic heart failure and palliative home care. PREFER: a randomized controlled study.
Eur J Heart Fail., 16 (2014), pp. 1142-1151
A.C. Sidebottom, A. Jorgenson, H. Richards, J. Kirven, A. Sillah.
Inpatient palliative care for patients with acute heart failure: outcomes from a randomized trial.
J Palliat Med., 18 (2015), pp. 134-142
J.F. Pattenden, A.R. Mason, R.J. Lewin.
Collaborative palliative care for advanced heart failure: outcomes and costs from the ‘Better Together’ pilot study.
BMJ Support Palliat Care., 3 (2013), pp. 69-76
D.T. Greener, T. Quill, O. Amir, J. Szydlowski, R.E. Gramling.
Palliative care referral among patients hospitalized with advanced heart failure.
J Palliat Med., 17 (2014), pp. 1115-1120
M.H. Cheang, G. Rose, C.C. Cheung, M. Thomas.
Current challenges in palliative care provision for heart failure in the UK: a survey on the perspectives of palliative care professionals.
Open Heart., 2 (2015), pp. e000188
A. Gadoud, E. Kane, U. Macleod, P. Ansell, S. Oliver, M. Johnson.
Palliative care among heart failure patients in primary care: a comparison to cancer patients using English family practice data.
PLoS One., 9 (2014), pp. e113188
D. Kavalieratos, E.M. Mitchell, T.S. Carey, S. Dev, A.K. Biddle, B.B. Reeve, et al.
“Not the ‘grim reaper service”’: an assessment of provider knowledge, attitudes, and perceptions regarding palliative care referral barriers in heart failure.
J Am Heart Assoc., 3 (2014), pp. e000544
Centers for Medicare & Medicaid Services (CMS), HHS.
Medicare and Medicaid programs: hospice conditions of participation.
Final rule. Fed Regist., 73 (2008), pp. 32087-32220
D.J. Whellan, M. Cox, A.F. Hernandez, P.A. Heidenreich, L.H. Curtis, E.D. Peterson, et al.
Utilization of hospice and predicted mortality risk among older patients hospitalized with heart failure: findings from GWTG-HF.
J Card Fail., 18 (2012), pp. 471-477
NHPCO Facts and Figures: Hospice Care in America. Alexandria, Virginia: National Hospice and Palliative Care Organization; 2013.
S.J. Wingate, S.J. Goodlin.
Where's the data: heart failure admissions to hospice.
J Card Fail., 12 (2006), pp. S124
S. Blecker, G.F. Anderson, R. Herbert, N.Y. Wang, F.L. Brancati.
Hospice care and resource utilization in Medicare beneficiaries with heart failure.
Med Care., 49 (2011), pp. 985-991
K.T. Unroe, M.A. Greiner, A.F. Hernandez, D.J. Whellan, P. Kaul, K.A. Schulman, et al.
Resource use in the last 6 months of life among Medicare beneficiaries with heart failure, 2000-2007.
Arch Intern Med., 171 (2011), pp. 196-203
J. Wilson, S. McMillan.
Symptoms experienced by heart failure patients in hospice care.
J Hosp Palliat Nurs., 15 (2013), pp. 13-21
J.G. Cleland, I. Ekman.
Enlisting the help of the largest health care workforce—patients.
JAMA., 304 (2010), pp. 1383-1384
H.M. Krumholz, J. Amatruda, G.L. Smith, J.A. Mattera, S.A. Roumanis, M.J. Radford, et al.
Randomized trial of an education and support intervention to prevent readmission of patients with heart failure.
J Am Coll Cardiol., 39 (2002), pp. 83-89
L.H. Powell, J.E. Calvin Jr., D. Richardson, I. Janssen, C.F. Mendes de Leon, K.J. Flynn, HART Investigators, et al.
Self-management counseling in patients with heart failure: the heart failure adherence and retention randomized behavioral trial.
JAMA., 304 (2010), pp. 1331-1338
E. Lycholip, J. Celutkiene, A. Rudys, R. Steponeniene, A. Laucevicius.
Patient education significantly improves quality of life, exercise capacity and BNP level in stable heart failure patients.
Acta Cardiol., 65 (2010), pp. 549-556
H.C. Wijeysundera, M. Machado, X. Wang, G. Van Der Velde, N. Sikich, W. Witteman, et al.
Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario.
Canada. Value Health., 13 (2010), pp. 915-921
F. Dusemund, M. Steiner, A. Vuilliomenet, C. Muller, R. Bossart, K. Regez, et al.
Multidisciplinary Assessment to Personalize Length of Stay in Acute Decompensated Heart Failure (OPTIMA II ADHF).
J Clin Med Res., 4 (2012), pp. 402-409
P. Martineau, M. Frenette, L. Blais, C. Sauve.
Multidisciplinary outpatient congestive heart failure clinic: impact on hospital admissions and emergency room visits.
Can J Cardiol., 20 (2004), pp. 1205-1211
J. Sochalski, T. Jaarsma, H.M. Krumholz, A. Laramee, J.J. McMurray, M.D. Naylor, et al.
What works in chronic care management: the case of heart failure.
Health Aff (Millwood)., 28 (2009), pp. 179-189
A. Ducharme, O. Doyon, M. White, J.L. Rouleau, J.M. Brophy.
Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial.
CMAJ., 173 (2005), pp. 40-45
R. Jain, A. Evenson, R. Jain, E. Biddison, D. Dalal, K.M. Kelly, et al.
Efficacy of multidisciplinary outpatient management (MOM) program in long term heart failure care.
South Med J., 103 (2010), pp. 131-137
C.E. Smith, U. Piamjariyakul, J.A. Wick, J.A. Spertus, C. Russell, K.M. Dalton, et al.
Multidisciplinary group clinic appointments: the Self-Management and Care of Heart Failure (SMAC-HF) trial.
Circ Heart Fail., 7 (2014), pp. 888-894
C.T. Mao, M.H. Liu, K.H. Hsu, T.C. Fu, J.S. Wang, Y.Y. Huang, et al.
Effect of multidisciplinary disease management for hospitalized heart failure under a national health insurance programme.
J Cardiovasc Med (Hagerstown)., (2014),
R. Holland, J. Battersby, I. Harvey, E. Lenaghan, J. Smith, L. Hay.
Systematic review of multidisciplinary interventions in heart failure.
Heart., 91 (2005), pp. 899-906
F.H. Gwadry-Sridhar, V. Flintoft, D.S. Lee, H. Lee, G.H. Guyatt.
A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure.
Arch Intern Med., 164 (2004), pp. 2315-2320
F.A. McAlister, S. Stewart, S. Ferrua, J.J. McMurray.
Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials.
J Am Coll Cardiol., 44 (2004), pp. 810-819
D. Knox, L. Mischke.
Implementing a congestive heart failure disease management program to decrease length of stay and cost.
J Cardiovasc Nurs., 14 (1999), pp. 55-74
W.A. Gattis, V. Hasselblad, D.J. Whellan, C.M. O’Connor.
Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study.
Arch Intern Med., 159 (1999), pp. 1939-1945
E.K. Kasper, G. Gerstenblith, G. Hefter, E. Van Anden, J.A. Brinker, D.R. Thiemann, et al.
A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission.
J Am Coll Cardiol., 39 (2002), pp. 471-480
H.C. Wijeysundera, G. Trubiani, X. Wang, N. Mitsakakis, P.C. Austin, D.T. Ko, et al.
A population-based study to evaluate the effectiveness of multidisciplinary heart failure clinics and identify important service components.
Circ Heart Fail., 6 (2013), pp. 68-75
Copyright © 2015. Sociedad Española de Cardiología
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.